These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 33049555)

  • 21. Privatization and quality: Evidence from elderly care in Sweden.
    Bergman MA; Johansson P; Lundberg S; Spagnolo G
    J Health Econ; 2016 Sep; 49():109-19. PubMed ID: 27394007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public procurement of health technologies in Greece in an era of economic crisis.
    Kastanioti C; Kontodimopoulos N; Stasinopoulos D; Kapetaneas N; Polyzos N
    Health Policy; 2013 Jan; 109(1):7-13. PubMed ID: 22502936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical technology procurement in Europe: a cross-country comparison of current practice and policy.
    Sorenson C; Kanavos P
    Health Policy; 2011 Apr; 100(1):43-50. PubMed ID: 20846739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing procurement behaviour and decision-making: an exploratory qualitative study in a UK healthcare provider.
    Boulding H; Hinrichs-Krapels S
    BMC Health Serv Res; 2021 Oct; 21(1):1087. PubMed ID: 34645449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospital pricing: cost shifting and competition.
    Morrisey MA
    EBRI Issue Brief; 1993 May; (137):1-17. PubMed ID: 10129621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purchasing medical devices: The role of buyer competence and discretion.
    Bucciol A; Camboni R; Valbonesi P
    J Health Econ; 2020 Dec; 74():102370. PubMed ID: 33049555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [French national overview of the inclusion of environmental criteria in the public purchasing of health products (drugs and sterile medical devices)].
    Giraud JS; Hamidou F; Hassani Y; Borel C; Le Gonidec P
    Ann Pharm Fr; 2022 Mar; 80(2):216-226. PubMed ID: 34153241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
    Acosta A; Ciapponi A; Aaserud M; Vietto V; Austvoll-Dahlgren A; Kösters JP; Vacca C; Machado M; Diaz Ayala DH; Oxman AD
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005979. PubMed ID: 25318966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Public expenditure for plasma-derived and recombinant medicinal products in Italy.
    Lanzoni M; Candura F; Calizzani G; Biffoli C; Grazzini G
    Blood Transfus; 2013 Sep; 11 Suppl 4(Suppl 4):s110-7. PubMed ID: 24333303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods for medical device and equipment procurement and prioritization within low- and middle-income countries: findings of a systematic literature review.
    Diaconu K; Chen YF; Cummins C; Jimenez Moyao G; Manaseki-Holland S; Lilford R
    Global Health; 2017 Aug; 13(1):59. PubMed ID: 28821280
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.